Siemens tries to enter the breast tomosynthesis market; Multiple scans for non-Hodgkin's lymphoma patients increase risk for other cancers;

News From Around the Web

> Siemens Healthcare has submitted a premarket approval application for the MAMMOMAT Inspiration with digital breast tomosynthesis option to the U.S. Food and Drug Administration, according to Diagnostic Imaging. Siemens is only the second manufacturer to try to enter the U.S. tomosynthesis market, which currently is dominated by Hologic. Article

> Patients with non-Hodgkin's lymphoma who undergo eight or more CT scans double their risk of developing secondary primary malignancies, Medscape Medical News reports. According to researchers from Taipei Veterans General Hospital in Taiwan, the malignancies are typically located in the areas where the radiation fields of thoracic and abdominal CT scans overlap. Article

Health IT News

> Before deciding whether to go through with a medical procedure, it's important for patients to balance their expectations on recovery. A new data-driven tool being developed allows them to do just that. Article

Health Finance News

> Despite fears that healthcare inflation may be on the rise, new economic data suggests just the opposite. The White House Council of Economic Advisers, citing data from the Bureau of Economic Analysis (BEA), concluded that the drop in gross domestic product (GDP) during the first quarter of this year was linked in part to a drop in healthcare spending. Overall, the BEA concluded that a decline in healthcare spending contributed to a 0.2 percent drop in the overall GDP. During the first quarter, economic growth declined by 2.9 percent. Article

And Finally... No good deed goes unpunished. Article

Suggested Articles

Key lawmakers are fed up with what they see as poor VA leadership over a new Cerner EHR system and vowed to take tighter control of the project.

The latest report from The Leapfrog Group, an independent hospital safety watchdog group, looked specifically at surgical volumes of 2,100 hospitals.

Teladoc is playing an active role in preparations for a potential U.S. coronavirus outbreak and is working with the CDC to help track diseases.